Oncology Room
In this room you can find updates and expert discussions in oncology.
Patients with cholangiocarcinoma set to benefit from life extending treatment
Some people who have cholangiocarcinoma are now set to benefit from life-extending treatment pemigatinib after NICE published final draft guidance recommending it.
#VisualAbstract: Combination therapy using conformation-specific KIT inhibitors associated with clinical benefit in patients with advanced gastrointestinal stromal tumors
Abiraterone not recommended for certain type of prostate cancer
NICE has issued final draft guidance which does not recommend the treatment for newly diagnosed high-risk hormone-sensitive metastatic prostate cancer.
NICE recommends treatment for early stage mycosis fungoides-type cutaneous T-cell lymphoma
Chlormethine gel is recommended in final draft guidance following the agreement of a new commercial discount.
Positive EAMS scientific opinion for tepotinib for the treatment of advanced NSCLC
Tepotinib is a targeted therapy for non-small cell lung cancer with abnormal changes in the mesenchymal-epithelial transition factor gene (MET).
SMC accepts treatment for hepatocellular carcinoma
Atezolizumab is accepted for use within NHS Scotland for adult with advanced or unresectable disease who have not received prior systemic therapy.